Form 4: Lilly Endowment Inc. Sells Shares in Eli Lilly & Co.

Lilly Endowment Inc., a significant shareholder of Eli Lilly & Co., sold a portion of its common stock holdings in multiple transactions on January 10, 2024.

Summary

• Lilly Endowment Inc. sold a total of 163,829 shares of Eli Lilly & Co. common stock on January 10, 2024.
• The sales were executed in multiple transactions at varying weighted average prices.
• The prices ranged from $630.19 to $636.288 per share.
• Following these transactions, Lilly Endowment Inc. still holds 99,556,154 shares of Eli Lilly & Co. common stock.

Sentiment

Score: 5

Explanation: The document is a routine filing of a stock sale by a major shareholder, which is neither positive nor negative in itself.

Industry Context

This filing reflects a routine transaction by a major shareholder and is not indicative of any specific industry trend or competitive shift.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting changes in beneficial ownership by significant shareholders in publicly traded companies.
• The transaction size is relatively small compared to the total outstanding shares of Eli Lilly & Co., and is not unusual for large institutional investors to periodically adjust their holdings.
• Other large shareholders of Eli Lilly & Co. would also be expected to file similar forms when they make changes to their holdings.

Stakeholder Impact

• The sale of shares by Lilly Endowment Inc. may have a minor impact on the stock price of Eli Lilly & Co., but is unlikely to have a significant effect on other stakeholders.

Key Dates

Keywords

Eli Lilly & Co, Lilly Endowment Inc, stock sale, shareholder, common stock, transaction